Joint Pain Injections Market Size

Joint Pain Injections Market size was over USD 6 billion in 2024 and is estimated to reach USD 20.3 billion by the end of 2037, expanding at a CAGR of 10.7% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of joint pain injections is assessed at USD 6.6 billion.

A key driver of the market growth is the aging population, which is more susceptible to chronic joint conditions, particularly in the developed and developing regions. According to the 2019 World Population Prospects, 1 in 6 people in the world will be over age 65, which is a big leap from 1 in 11 people in 2019. The rising incidence of obesity and sedentary lifestyles is further contributing to the growing need for joint pain management solutions worldwide.

As per the National Safety Council, injuries increased by 20% in 2021 from 2020, 12% in 2022, and now 2% in 2023. These rising numbers of physical injuries are also boosting the market growth. Disorders such as osteoarthritis, and other degenerative joint diseases are driving the market growth further. According to the Radiological Society of North America (RSNA) 2022, osteoarthritis affects 32.5 million adults in the U.S. 43% of people suffering from the disease are 65 or older and 88% of people with OA are 45 or older, and 62% of individuals with OA are women.  In 2023, 3.7 million people were treated in emergency departments for injuries involving sports and recreational equipment. These factors are projected to significantly boost the joint pain injections market growth during the forecast period.